MedPath

Metformin treatment among pregnant women with fatty liver condition to prevent diabetes during pregnancy

Phase 2
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classifiedHealth Condition 2: O266- Liver and biliary tract disordersin pregnancy, childbirth and the puerperium
Registration Number
CTRI/2023/12/060930
Lead Sponsor
Directorate of Health Research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

without a prior history of gestational diabetes mellitus, not on any hypoglycaemic drugs with competent mental health status.

Exclusion Criteria

with a history of advanced medical conditions such as chronic liver disease, hypertensive disorders, advanced stage renal disease and known allergic to the drug Metformin

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath